Lakewood Capital Opens Shorts In Seagate, Diplomat Pharmacy, Ziopharm OncologyRupert Hargreaves
Lakewood Capital Management, the hedge fund managed by Anthony T. Bozza, recorded a net loss of 2.4% for the third quarter, according to the fund’s third quarter letter to partners reviewed by ValueWalk.
In Lakewood’s words the performance, “underscored the fund’s conservative orientation and careful approach to risk management”. Long equity positions generated a -9% return on capital, hedged long equity positions generated a -4% return on . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.